Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Boston Scientific (BSX) Any Comments??? -- Ignore unavailable to you. Want to Upgrade?

To: yard_man who wrote (485)	9/16/1998 5:21:00 PM
From: OldAIMGuy	Read Replies (1) \| Respond to of 798

Hi T, Valuation is part of good stock selection. AIM's a purely mathematical risk governor. I've found that now that I know AIM's "personality", I'm much better at picking stocks for its use. A stock with solid fundamental values that's followed by the quarterly report addicts is just right for AIM. "Disappoint" translates into AIM Buys. "Exceeded expectations" translates into AIM Sells. The portfolio builds out of the realized capital gains of each cycle. Hope this discussion isn't offending anyone else here! We AIMers have a topic here on SI at: Subject 12596 It's a good bunch of folks, sort of the SI Optimists Club!! (even if I do say so myself!) Best regards, Tom